Amdocs Limited DOX
57.71
(0.65)
(1.11%)
as of 25 Sep
- Market cap
- $6.2B
- P/E
- 13.7×
Follow DOX
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
16.18 | 15.51 | 13.00 | 11.98 |
P/S ratio |
1.97 | 1.90 | 1.48 | 1.12 | |
P/FCF ratio |
13.87 | 11.51 | 10.09 | 8.19 | |
P/Operating CF |
38.93 | 39.46 | 67.42 | 26.52 | |
P/B ratio |
2.58 | 2.51 | 2.00 | 1.57 | |
Price to Tangible BV |
21.12 | 39.95 | 38.15 | 50.46 | |
EV/Sales |
2.09 | 2.04 | 1.66 | 1.31 | |
EV/EBITDA |
10.19 | 9.96 | 8.24 | 7.28 | |
EV/Operating CF |
12.62 | 10.83 | 9.67 | 8.11 | |
EV/FCF |
14.65 | 12.39 | 11.29 | 9.51 | |
Quick Ratio |
0.93 | 0.83 | 0.75 | 0.71 | |
Current Ratio |
1.17 | 1.06 | 0.98 | 0.94 | |
Net Debt/EBITDA |
2.52 | 2.59 | 3.46 | 5.38 | |
Debt/Assets |
12.60% | 14.42% | 16.21% | 16.40% | |
Debt/Equity |
0.23 | 0.26 | 0.30 | 0.32 | |
Asset Turnover |
0.72 | 0.72 | 0.74 | 0.73 | |
Operating CF/Net income |
2.59 | 1.40 | 0.74 | 3.23 | |
Capex/Depreciation |
(0.61) | (0.63) | (0.40) | (0.48) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
7.64% | 7.09% | 7.42% | 7.35% | |
Selling, General and Administrative Expense of Revenue |
10.59% | 9.84% | 13.11% | 12.70% | |
Intangible Assets out of Total Assets |
0.49 | 0.51 | 0.51 | 0.50 | |
Share Based Compensation of Revenue |
2.32% | 2.08% | 3.24% | 1.84% | |
Graham Net Nets |
(0.13) | (0.15) | (0.21) | (0.29) | |
Graham Number |
60.25 | 61.23 | 60.70 | 55.26 | |
Earnings Yield |
6.18% | 6.45% | 7.69% | 8.35% | |
Free Cash Flow Yield |
7.21% | 8.69% | 9.91% | 12.22% | |
Revenue per Share |
10.55 | 10.71 | 11.17 | 11.35 | |
Operating CF per Share |
2.11 | 2.04 | 0.97 | 1.91 | |
Capex per Share |
(0.29) | (0.30) | (0.20) | (0.24) | |
Free Cash Flow per Share |
1.82 | 1.74 | 0.77 | 1.66 | |
Cash per Share |
2.98 | 2.30 | 2.04 | 2.00 | |
Shareholders Equity per Share |
31.82 | 32.11 | 32.62 | 32.16 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
31.82 | 32.11 | 32.62 | 32.16 | |
Free Cash Flow |
198.63 | 187.94 | 80.35 | 171.92 | |
Working Capital |
233.35 | 83.09 | (30.27) | (109.73) | |
Capital Expenditures |
(31.21) | (32.24) | (21.24) | (25.29) | |
Net Current Asset Value |
(1,187.01) | (1,335.08) | (1,423.42) | (1,495.99) | |
EV/EBIT |
12.92 | 12.65 | 10.58 | 9.69 | |
Capex to Sales |
0.03 | 0.03 | 0.02 | 0.02 | |
Net Profit Margin |
7.71% | 13.63% | 11.76% | 5.19% | |
Price to Operating Income |
12.23 | 11.75 | 9.45 | 8.34 | |
| Other line items | |||||
Average Receivables |
982.05 | 976.82 | 948.02 | 983.10 | |
Average Payables |
338.55 | 347.83 | 345.14 | 375.45 | |
Average Assets |
6,317.99 | 6,318.91 | 6,284.21 | 6,374.24 | |
Average Common Equity |
3,484.93 | 3,485.49 | 3,462.82 | 3,436.46 |
Columns are period end dates